The 1 analysts offering 12-month price forecasts for Aileron Therapeutics Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,293.73% increase from the last price of 2.87.
The current consensus among 4 polled investment analysts is to Hold stock in Aileron Therapeutics Inc. This rating has held steady since July, when it was downgraded from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$1.32
Reporting Date Apr 03
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.